Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Healthcare Cannabis
Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.


GREY:ALEAF - Post by User

Aleafia Health Inc > Johnson & Johnson subsidiary Janssen approves Aleafia
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Nonyahon Jul 24, 2020 8:49am
174 Views
Post# 31312972

Johnson & Johnson subsidiary Janssen approves Aleafia

Johnson & Johnson subsidiary Janssen approves AleafiaJohnson & Johnson subsidiary Janssen approves Aleafia Health to admin Spravato. Spravato is a Ketamine based Nasal Spray which cost patients 3k- 5k per session. Currently, Aleafia Health has been approved for 3 locations to admin this drug from the gods. Totally, Aleafia Health has 25-40 locations Throughout Canada, some ready to admin and some clinics need retrofitting. Now that the clinics are fully paid for, the Sky is the limit
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities